In March of this year, a joint inspection team from the Guangdong Provincial Drug Administration and the Huangpu District Market Supervision Administration in Guangzhou conducted a comprehensive two-day on-site inspection of the quality management system related to DiQi Pharmaceuticals Co., Ltd's marketing authorization holder. The inspection team gave a positive evaluation of DiQi Pharmaceuticals Co., Ltd's quality management system.

DiQi Pharmaceuticals Co., Ltd. is a pharmaceutical company integrating technical services with independent R&D, specializing in the development of modified innovative drug technologies and the industrialization of products. Our mission is to develop and manufacture high-quality, highly effective, long-acting, and highly compliant medicines that are affordable for the public, aiming to become a leading enterprise in high-end pharmaceutical formulations! The acquisition of this Drug Manufacturing License signifies that DiQi Pharmaceuticals Co., Ltd.'s independently owned products have officially entered the commercial production phase.

DiQi Pharmaceuticals Co., Ltd. will accelerate the industrialization of multiple innovative products to benefit the public and fulfill its mission: Crafting quality medicines, building a legacy!